Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic
Patent
1999-06-21
2000-08-08
Housel, James C.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Anti-idiotypic
4241301, 4241331, 4241371, 4241641, 4241341, 4241411, 5303872, 5303875, 5303884, A61K 39395, A61K 3940
Patent
active
060998393
ABSTRACT:
The present invention relates to anti-against idiotypic antibodies directed against Neisseria gonorrhoeae. This invention also relates to methods and compositions using such anti-idiotypic antibodies for the prophylaxis, treatment and diagnosis of gonorrheal infections.
REFERENCES:
patent: 4699880 (1987-10-01), Goldstein
patent: 5476784 (1995-12-01), Rice et al.
patent: 5888509 (1999-03-01), Rice et al.
Apicella, M.A., M.A.J. Westerink, S.A. Morse, H. Schneider, P.A. Rice and J.M. Griffiss. 1986. Bactericidal antibody response of normal human serum to the lipooligosaccharide Neisseria gonorrhoeae. J. Infect. Dis. 153:520-526.
Apicella, M.A., R.E. Mandrell, M. Shero, M.E. Wilson, J. McLeod Griftis, G.F. Brooks, C. Lamarel, J.F. Breen and P.A. Rice. 1990. Modification of sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J. Infect. Dis. 162:506-512.
Britigan, B.E., M.S. Cohen and P.F. Sparling. 1985. Gonococcal infection: a model of molecular pathogenesis. N. Eng. J. Med. 312:1683-1694.
Brodin, N.T., J. Dahmen, B. Nilsson, L. Messeter, S. M.ang.rtenson, J. Heldrup, H.O. Sjogren and A. Lundblad. 1988. Monoclonal antibodies produced by immunization with neoglycoproteins containing Gal.alpha.1.fwdarw.4.beta.1.fwdarw.4G1c.beta.-O and Gal.alpha.1.fwdarw.4G1cNAc.beta.-O residues: useful immunochemical and cytochemical reagents for blood group P antigens and a differentiation marker in Burkitt lymphoma and other B-cell malignancies. Int. J. Cancer. 42:185-194.
Brooks, G.F. and C.J. Lammell. 1989. Humoral immune response to gonococcal infection. Clin. Micro. Rev. 2:S5-S10.
Brossay, L. et al., "Iodiotype and Anti-Anti-idiotype Antibodies to Neisseria Gonorrhoeae Lipooligosaccharides with Bactericidal Activity but No Cross-Reactivity with Red Blood Cell Antigens", J. Immunol., 151, pp. 234-43 (1993).
Brossay, L., G. Paradis, A. Pepin, E. Gagnon, L. Cote, J. Hebert. 1992. Poster Presentation II-4, p. 148, The Eighth International Pathogenic Neisseria Conference, Oct. 4-9, 1992 (Cuernavaca, Mexico).
CDC. 1991. Pelvic Inflammatory Disease: Guidelines for Prevention and Management. MMWR 40:1-25.
CDC. 1982. Sexually transmitted diseases treatment guidelines. MMWR 31:37S-42S 375-425.
CDC. 1984. Chromosomally mediated resistant Neisseria gonorrhoeae-United States. MMWR 33:408-410.
Cohen, I.R., D.S. Kellogg and L.C. Norins. 1969. Serum antibody response in experimental human gonorrhoeae: Immunoglobulins G, A and M. Br. J. Ven. Dis. 45:325-327.
Densen, P., S. Gulati and P.A. Rice. 1987, Specificity of antibodies against Neisseria gonorrhoeae that stimulate neutrophil chemotaxis. J. Clin. Invest. 80:78-87.
Fohn, M.J., T.A. Mietzner, T.W. Hubbard, S.A. Morse and E.W. Hook III. 1987. Human immunoglobulin G antibody response to the major gonococcal iron-regulated protein. Infect. Immun. 55:3065-3069.
Glynn, A.A. and M.E. Ward. 1970. Nature and heterogeneity of the antigens of Neisseria gonorrhoeae involved in the serum bactericidal reaction. Infect. Immun. 2:162-168.
Gnehm, H.E., S.I. Pelton, S. Gulati and P.A. Rice. 1985. Characterization of antigens from nontypable Haemophilus influenzas recognized by human bactericidal antibodies. J. Clin. Invest. 75:1645-1658.
Griffiss, H.M., J.P. O'Brien, R. Yamasaki, G.D. Williams, P.A. Rice and H. Schneider. 1987. Physical heterogeneity of Neisserial lipooligosaccharides reflects oligosaccharides that differ in apparent molecular weight, chemical composition, and antigenic expression. Infect. Immun. 55:1792-1800.
Harris, W.J. et al., "Therapeutic antibodies--the coming of age," TIBTECH, 11: 42-44, 1993.
Horng, W.J., "Selective Enhancement of a Subpopulation of Anti-Neisseria gonorrhoeae Antibodies in Rabbits Through a Reverse Stimulation by Anti-Idiotype Antibodies", Fed. Amer. Soc. Exp. Biol., 69th Ann. Meet., Apr. 21-26, 1985 (Anaheim, California), Abstract No. 7502, p. 1694.
Jerne, N.K. 1974, Towards a network theory of the immune system. Ann. Immun. Inst. Pasteur. 125C:373-389.
Joiner, K.A., R. Scales, J.A. Warren, M.M. Frank and P.A. Rice. 1985. Mechanism of action of blocking immunoglobulin G for Neisseria gonorrhoeae. Clin. Invest. 76:1765-1772.
Kasper, D.L., P.A. Rice and W.M. McCormack. 1977. Bactericidal antibody in genital infection due to Neisseria gonorrhoeae. J. Infect. Dis. 135:243-251.
Kennedy, R.C., K. Adler-Storthe, R.D. Henkel, Y. Sanchez, J..L. Melnick nad G.R. Dreesman. 1983. Immune response to hepatitis B surface antigen: enhancement by prior injection of antibodies to the idiotype. Science 221:853-855.
Kennedy, R.C., J.W. Eichberg, R.E. Landford and G.R. Dressman. 1986. Anti-idiotypic vaccine for type B viral hepatitis in chimpanzees. Science 232:220-223.
Kieber-Emmons, T., R.E. Ward, S. Raychaudhuri, R. Rein and H. Kohler. 1986. Rational design and application of idiotope vaccines. Int. Rev. Immunol. 1:1-26.
Kim, J.J., R.E. Mandrell, H. Zhen, M.A.J. Westerink, J.T. Poolman and J.M. Griffiss. 1988. Electromorphic characterization and description of conserved epitopes of the lipooligosaccharides of group A Neisseria meningitidis. Infect. Immun. 56:2631-2638.
Lambden, P.R., J.E. Heckels, H. McBride and P.J. Watt. 1981. The identification and isolation of novel pilus types produced by variants of Neisseria gonorrhoeae P9 following selection in vivo. FEMS. Microbiol. Lett. 10:339-341.
Lammel, C.J., R.L. Sweet, P.A. Rice, J.S. Knapp, G.K. Schoolnik, D.C. Heilbron and G.F. Brooks. 1985. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J. Infect. Dis. 152:990-1001.
Mandrell, R.E., H. Schneider, M.A. Apicella, W.D. Zollinger, P.A. Rice and J.M. Griffiss. 1986. Antigenic and physical diversity of Neisseria gonorrhoeae lipooligosaccharides. Infect. Immun. 54:63-69.
Mandrell, R.E., J.M. Griffiss and B.E. Macher. 1988. Lipooigosaccharides (LOS) of Neisseria gonorrhoeae and Neisseria meningitidis have components that are immunochemically similar to precursors of human blood group antigens: carbohydrate sequence specificity of the mouse monoclonal antibodies that recognize crossreacting antigens on LOS and human erythrocytes. J. Exp. Med. 168:107-126.
Mandrell, R.E. 1992. Further antigenic similarities of Neisseria gonorrhoeae lipooligosaccharides and human glycosphingolipids. Infect. Immun. 60:3017-3020.
Morse, S.A., S. Stein and J. Hines. 1974. Glucose metabolism in Neisseria gonorrhoeae. J. Bact. 120:702-714.
Newhall, W.J., W.D. Sawyer, and R.A. Haak. Cross-linking analysis of the outer membrane proteins of Neisseria gonorrhoeae. Infect. Innum. 28:785-791.
Nisonoff, A. and E. Lamoyi. 1981. Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production. Clin. Immunol. Immunopathol. 21:397-406.
Rice, P.A. and D.L. Kasper. 1977. Characterization of gonococcal antigens responsible for induction of bactericidal antibody in disseminated infection. J. Clin. Invest. 60:1149-1158.
Rice, P.A. and D.L. Kasper. 1982. Characterization of serum resistance of Neisseria gonorrhoeae that disseminate. J. Clin. Invest. 70:157-167.
Rice, P.A., H.E. Vayo, M.R. Tam and M.S. Blake. 1986. Immunoglobulin G antibodies directed against protein III block killing of serum resistant Neisseria gonorrhoeae by immune serum. J. Exp. Med. 164:1735-1748.
Rice, P.A. 1989. Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin. Micro. Rev. 2S:S112-S117.
Roberts, R.B. 1967. The interaction in vitro between Group B meningococci and rabbit polymorphonuclear leukocytes. J. Exp. Med. 126:795-817.
Ross, S.C. and P. Densen. 1985. Opsonophagocytosis of Neisseria gonorrhoeae: interaction of local and disseminated isolates with complement and neutrophils. J. Infect. Dis. 151:33-41.
Schoolnik, G.K. and Mietzner, T.A. 1992. Vaccines against gonococcal infections. In: G.C. Woodrow and M.M.Levine (ed.), New Generation Vaccines, Marcel Dekker, Inc. New York, 565-597.
Schoolnik, G.K. and Z.A. McGee. 1985. Gonococcal vaccine development strategies: summary of the recommendations of
Gulati Sunita
McQuillen Daniel P.
Rice Peter A.
Devi S.
Housel James C.
Pierri Margaret A.
Rochester S. Craig
LandOfFree
Gonococcal anti-idiotypic antibodies and methods compositions us does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gonococcal anti-idiotypic antibodies and methods compositions us, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gonococcal anti-idiotypic antibodies and methods compositions us will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1147696